Oncology Pharma Inc ONPH:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/06/24 EDT
0.0001UNCH (UNCH)
52 week range
0.00 - 1.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High1.05
  • 52 Week High Date06/13/23
  • 52 Week Low0.00
  • 52 Week Low Date05/03/24

Key Stats

  • Market Cap3,856.322
  • Shares Out38.56M
  • 10 Day Average Volume6,512.43
  • Dividend-
  • Dividend Yield-
  • Beta9.89
  • YTD % Change-50

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High1.05
  • 52 Week High Date06/13/23
  • 52 Week Low0.00
  • 52 Week Low Date05/03/24
  • Market Cap3,856.322
  • Shares Out38.56M
  • 10 Day Average Volume6,512.43
  • Dividend-
  • Dividend Yield-
  • Beta9.89
  • YTD % Change-50

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-22.008M
  • ROE (TTM)-
  • Revenue (TTM)29,530.00
  • Gross Margin (TTM)63.93%
  • Net Margin (TTM)-75,137.22%
  • Debt To Equity (MRQ)-357.38%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oncology Pharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The Company offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody...
Address
1 Sansome St Ste 3500
San Francisco, CA
94104-4436
United States